Vifor Pharma (United States)

Vifor Pharma (United States)

CSL Vifor is a global specialty pharmaceuticals company in the treatment areas of iron deficiency, dialysis, nephrology & rare disease. It is headquartered in Switzerland and consists of CSL Vifor, Vifor Fresenius Medical Care Renal Pharma and Sanifit Therapeutics. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Vifor Pharma (United States), United States, covering academic research published from 2000 to 2023. Read More.


Open Access Percentage

61%


Total
Publications

127


Total Open
Publications

78


Total
Citations

2.4K


Open Access
Percentage

61%


Total
Publications

127


Total Open
Publications

78


Total
Citations

2.4K

Wikipedia

Website

download

Breakdown

21% 34% 6% 39%

Publisher Open

21%

Both

34%

Other Platform Open

6%

Closed

39%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

0246810121416182022Total Publications
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Open

Closed

Publisher Open

36%OA Journal

OA Journal 36%

25

Hybrid 30%

21

No Guarantees 34%

24

Other Platform Open

Domain 84%

43

Institution 20%

10

Preprint 12%

6

Other Internet 8%

4

Public 6%

3

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
43
Europe PMC
Domain
23
University College London - UCL Discovery
Institution
8
Research Square
Preprint
6
University of Michigan - Deep Blue
Institution
2
Le Centre pour la Communication Scientifique Directe - HAL - Inria
Institution
2
Le Centre pour la Communication Scientifique Directe - HAL - Diderot
Institution
2
Elsevier - Scopus
Other Internet
2
University of Zurich - Zurich Open Repository and Archive
Institution
1
University of Oxford - Oxford University Research Archive (ORA)
Institution
1
1 / 3

Data updated 17 June 2024

Share

Share

Share